Display options
Cite
Bhamidipati D, Anand S, Gothwal A, et al. On the underreporting of health-related quality of life and regulatory approval. Ann Oncol. 2019;30(4):657-658doi: 10.1093/annonc/mdz033.
Bhamidipati, D., Anand, S., Gothwal, A., Raghav, K., & Overman, M. J. (2019). On the underreporting of health-related quality of life and regulatory approval. Annals of oncology : official journal of the European Society for Medical Oncology, 30(4), 657-658. https://doi.org/10.1093/annonc/mdz033
Bhamidipati, D, et al. "On the underreporting of health-related quality of life and regulatory approval." Annals of oncology : official journal of the European Society for Medical Oncology vol. 30,4 (2019): 657-658. doi: https://doi.org/10.1093/annonc/mdz033
Bhamidipati D, Anand S, Gothwal A, Raghav K, Overman MJ. On the underreporting of health-related quality of life and regulatory approval. Ann Oncol. 2019 Apr 01;30(4):657-658. doi: 10.1093/annonc/mdz033. PMID: 30698646.
Copy Download .nbib Format: NLM
Share it on

Ann Oncol. 2019 Apr 01;30(4):657-658. doi: 10.1093/annonc/mdz033.

On the underreporting of health-related quality of life and regulatory approval.

Annals of oncology : official journal of the European Society for Medical Oncology

D Bhamidipati, S Anand, A Gothwal, K Raghav, M J Overman

Affiliations

  1. Department of Internal Medicine, Baylor College of Medicine, Houston.
  2. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  3. Department of Biology, Baylor University, Waco, USA.
  4. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. Electronic address: [email protected].

PMID: 30698646 DOI: 10.1093/annonc/mdz033

[No abstract available.]

MeSH terms

Publication Types